Cargando…
Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
The majority of pancreatic ductal adenocarcinomas (PDAC) are diagnosed late so that surgery is rarely curative. Earlier detection could significantly increase the likelihood of successful treatment and improve survival. The aim of the study was to provide proof of principle that point mutations in k...
Autores principales: | Adamo, Patricia, Cowley, Caroline M, Neal, Christopher P, Mistry, Vilas, Page, Karen, Dennison, Ashley R, Isherwood, John, Hastings, Robert, Luo, JinLi, Moore, David A, Howard, Pringle J, Miguel, Martins L, Pritchard, Catrin, Manson, Margaret, Shaw, Jacqui A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5675628/ https://www.ncbi.nlm.nih.gov/pubmed/29152076 http://dx.doi.org/10.18632/oncotarget.20250 |
Ejemplares similares
-
Statins mediate anti- and pro-tumourigenic functions by remodelling the tumour microenvironment
por: Kamata, Tamihiro, et al.
Publicado: (2022) -
Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
por: Openshaw, Mark R., et al.
Publicado: (2020) -
Cellular heterogeneity in tumours.
por: Woodruff, M. F.
Publicado: (1983) -
Tumour Cell Heterogeneity
por: Gay, Laura, et al.
Publicado: (2016) -
Circulating tumour-derived DNA in metastatic soft tissue sarcoma
por: Eastley, Nicholas C., et al.
Publicado: (2018)